Tag Archives: ObsEva SA

H.C. Wainwright Reiterates a Buy Rating on ObsEva SA (OBSV)

In a report issued on October 5, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on ObsEva SA (NASDAQ: OBSV), with a price target of $23.00. The company’s shares closed last Tuesday at $2.55. Currently, the analyst consensus on

Analysts Offer Insights on Healthcare Companies: ObsEva SA (NASDAQ: OBSV) and Invitae (NYSE: NVTA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ObsEva SA (OBSV – Research Report) and Invitae (NVTA – Research Report) with bullish sentiments. ObsEva SA (OBSV) In a report released

Leerink Partners Thinks ObsEva SA’s Stock is Going to Recover

In a report released today, Ami Fadia from Leerink Partners maintained a Buy rating on ObsEva SA (OBSV – Research Report), with a price target of $5.00. The company’s shares closed last Tuesday at $3.04, close to its 52-week low

Wedbush Sticks to Their Buy Rating for ObsEva SA (OBSV)

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on ObsEva SA (OBSV – Research Report), with a price target of $30.00. The company’s shares closed last Monday at $3.25. According to TipRanks.com, Moussatos is a

Wedbush Remains a Buy on ObsEva SA (OBSV)

Wedbush analyst Liana Moussatos reiterated a Buy rating on ObsEva SA (OBSV – Research Report) today and set a price target of $36.00. The company’s shares closed last Monday at $3.95, close to its 52-week low of $2.37. According to

H.C. Wainwright Remains a Buy on ObsEva SA (OBSV)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on ObsEva SA (OBSV – Research Report) today and set a price target of $40.00. The company’s shares closed last Monday at $3.80, close to its 52-week low of $2.37. According